The clinical and laboratory findings in patients with severe COVID-19 are indicative of macrophage activation syndrome (40), which occurs in diverse clinical settings and is characterized by elevated CRP, IL-6 and other inflammatory cytokines, suggesting that the immunopathology of severe COVID-19 involves dysregulation of macrophage homeostasis. Here, IL6 is linked to macrophage activation syndrome.